INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Tuesday that it has received feedback from the U.S. Food and Drug Administration (FDA) that data from its completed Phase 1/2 trial of INO-3107 for the treatment of RRP could support INOVIO's submission of a BLA for review under the FDA's accelerated approval program.

RTTNews | 664 gün önce

INOVIO Says FDA Grants Breakthrough Therapy Designation For INO-3107; Stock Up 15%

Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Thursday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for INO-3107 as a potential treatment for patients with Recurrent Respiratory Papillomatosis (RRP).

RTTNews | 697 gün önce

INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

Biotechnology company INOVIO Pharmaceuticals, Inc. (INO) announced Thursday positive results from a Phase 1b clinical trial evaluating INO-4201, a DNA vaccine candidate, as a booster in healthy adult participants who previously received a single injection of Ervebo.

RTTNews | 914 gün önce

INOVIO Announces Corporate Reorganization, Including Workforce Reduction, To Reduce Expenses

Biotechnology company INOVIO (INO) announced Tuesday that it has implemented a corporate reorganization designed to extend its cash runway and to focus on key clinical programs with the goal to drive long-term growth.

RTTNews | 1112 gün önce

Renewed Support Likely For Malaysia Stock Market

The Malaysia stock market has alternated between positive and negative finishes through the last four trading days since the end of the three-day losing streak in which it had fallen more than 15 points or 1 percent. The Kuala Lumpur Composite Index now sits just above the 1,525-point plateau although it's likely to bounce higher again on Tuesday.

RTTNews | 4 dakika önce

Japan Stock Market May Stop The Bleeding On Tuesday

EURUSD	1.15847	GBPUSD	1.32988	AUDUSD	0.64735
USDJPY	146.756	USDCAD	1.37701	USDCHF	0.80702

INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

INOVIO Says FDA Grants Breakthrough Therapy Designation For INO-3107; Stock Up 15%

INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

INOVIO Announces Corporate Reorganization, Including Workforce Reduction, To Reduce Expenses

Renewed Support Likely For Malaysia Stock Market

Japan Stock Market May Stop The Bleeding On Tuesday

South Korea Inflation Rises 0.2% In July

Australia Services Sector Accelerates In July

Advertisement

INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis